“They’re constantly looking for new viruses, and in this case we set up a team to be able to monitor all the mutations that could exist,” Abbott CEO Robert Ford told CNBC, adding that global collaboration with other countries, universities and specimen collection sites is crucial.
In January, the FDA warned clinicians that new variants could cause false negative results for some molecular COVID-19 tests, none of which are made by Abbott.
Now, scientists are working to create tests that detect parts of the virus that are less likely to mutate and cause inaccurate results, according to CNBC.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
